Effects of The Nutritional Risk Screening 2002-based nutritional therapy on nutritional status and rehabilitation process in hemorrhagic stroke patients with dysphagia / 中国基层医药

ABSTRACT

Objective:To investigate the effects of The Nutritional Risk Screening 2002 (NRS-2002)-based nutritional therapy on nutritional status and rehabilitation process in hemorrhagic stroke patients with dysphagia.Methods:Eighty-eight hemorrhagic stroke patients with dysphagia who received treatment in Lishui Central Hospital, China between June 2018 and November 2020 were included in this study. They were randomly assigned to receive either routine treatment ( n = 44, control group) or routine treatment combined with NRS-2002-based nutritional therapy ( n = 44, observation group) for 4 successive weeks. The Kubota drinking test score, the National Institutes of Health Stroke Scale (NIHSS) score, clinical efficacy, and nutritional status were compared between the control and observation groups. Results:Compared with before treatment, the Kubota drinking test score and National Institutes of Health Stroke Scale score in each group were greatly decreased after treatment ( t = 9.393, 5.998, 25.851, 21.136, all P < 0.01). The Kubota drinking test score and NIHSS score in the observation group were significantly lower than those in the control group [(2.57 ± 0.30) points vs. (4.16 ± 0.49) points; (8.93 ± 1.01) points vs. (15.83 ± 2.03) points, t = 18.357, 20.186, both P < 0.01). Total effective rate in the observation group (93.18%) was significantly higher than that in the control group ( χ2 = 4.162, P < 0.05). Compared with before treatment, serum prealbumin, albumin, and hemoglobin levels in each group were significantly increased after treatment ( t = 2.551, 4.088, 2.600, 7.239, 7.540, 8.684, all P < 0.01). After treatment, serum prealbumin, albumin, and hemoglobin levels in the observation group were significantly higher than those in the control group ( t = 5.104, 3.439, 6.024, all P < 0.01). Conclusion:NRS-2002-based nutritional therapy can effectively improve the dysphagia, neurological function and nutritional status of patients with hemorrhagic stroke.